Cytosurge's CellEDIT Workflow, based on its Proprietary FluidFM® Technology, Receives Validation in Peer-Reviewed Publication

Contributed by: GlobeNewswire

Tags

CellEDIT workflow

More Like This

PR Newswire associated0

Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing

Cytosurge and Lexogen Partner to Advance Live-Cell Sequencing

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

CRISPR-Ready ioGlutamatergic Neurons (Graphic: Business Wire)

bit.bio introduces first product in groundbreaking ioCRISPR-Ready Cells™ product range, paving the way for new advances in disease modelling and drug discovery

PR Newswire associated0

Solvias to Perform Release Testing on World's First CRISPR-based Gene-Editing Therapy

PR Newswire associated0

EnGeneIC Selects Global CDMO BioCina to Advance Their Ground-Breaking Cancer Treatment

PR Newswire associated0

BioCina Acquires the Exclusive CDMO Rights for Leading-Edge Minicircle DNA Technology Platform from CelluTx

Business Wire logo

ViroCell Biologics to Host Panel Event at 2024 Cell & Gene Meeting on the Mesa